<DOC>
	<DOCNO>NCT00451334</DOCNO>
	<brief_summary>This study prospective , open label , control , single center study . 40 patient recruit study , accord patient ’ inflow meeting eligibility criterion . Primary Goal * To evaluate safety GlucoSat technology non-invasive blood glucose level measurement technology . Secondary Goal * To assess efficacy GlucoSat technology non-invasive blood glucose level measurement technology .</brief_summary>
	<brief_title>Safety Efficacy Using GlucoSat Technology For Non-Invasive Glucose Measurement</brief_title>
	<detailed_description>Primary Endpoint Parameter • Primary study endpoint establish safety use GlucoSat technology non-invasive glucose level measurement technology . Safety establish paucity adverse event . Adverse Events occurrence document throughout study . Secondary Endpoint Parameters Efficacy GlucoSat technology assess : - Proving accuracy precision GlucoSat technology compare glucose level measure GlucoSat device glucose level observe certified clinic invasive device . Inter device variability within 15 % . - Patient satisfaction questionnaire . - Physician satisfaction assess questionnaire .</detailed_description>
	<criteria>Male/Female age 18 . Subject diagnosed diabetes patient healthy subject . Subject able comprehend give inform consent participation study . Signed Informed Consent Form Pregnancy breast feeding . Patients treat steroid . Concomitant Coumadin use Recent ( within last 3 month ) myocardial infarction CVA ( stroke ) . Any chronic unstable disease within last 3 month . Acute bleed disorder . HIV positive . Hepatitis B/C positive . BMI &gt; 37 Needing emergency surgery Known cognitive psychiatric disorder Physician objection Concurrent participation clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2006</verification_date>
</DOC>